Tomohito Kuwako
Shibukawa, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Stage-specific efficacy of osimertinib in treatment-naïve EGFR-mutant non-small cell lung cancer according to baseline genetic alterations in circulating tumor DNA.
Journal: Investigational new drugs
Published: December 13, 2024
Serum galectin-3 as a biomarker of progression of idiopathic pulmonary fibrosis treated with nintedanib.
Journal: Respiratory investigation
Published: October 26, 2024
Baseline genetic abnormalities and effectiveness of osimertinib treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC based on performance status.
Journal: BMC pulmonary medicine
Published: June 27, 2024
Mechanisms of resistance and correlation between pre-treatment co-alterations and p-prognosis to osimertinib in chemo-naïve advanced non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 26, 2024
Probably the Mycobacterium avium Complex around the Staple Line Exacerbated after Radiation Therapy.
Probably the Mycobacterium avium Complex around the Staple Line Exacerbated after Radiation Therapy.
Journal: Case reports in infectious diseases
Published: June 26, 2021
Phase II Study of Weekly Nanoparticle Albumin-Bound Paclitaxel as Second- or Third-Line Therapy in Patients with Advanced Non-Small Cell Lung Cancer.
Journal: Chemotherapy
Published: January 21, 2020
Administration of docetaxel plus ramucirumab with primary prophylactic pegylated-granulocyte colony-stimulating factor for pretreated non-small cell lung cancer: a phase II study.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: October 07, 2019
Predictors of Discontinuance of Oral Feeding in Patients With Advanced Alzheimer Dementia and Aspiration Pneumonia in Japan: A Single-center, Retrospective Observational Study.
Journal: Alzheimer disease and associated disorders
Published: May 29, 2019
A phase II study of afatinib treatment for elderly patients with previously untreated advanced non-small-cell lung cancer harboring EGFR mutations.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 28, 2018
Evaluation of gefitinib efficacy according to body mass index, body surface area, and body weight in patients with EGFR-mutated advanced non-small cell lung cancer.
Journal: Cancer chemotherapy and pharmacology
Published: November 12, 2016
Hydroxyurea-induced Pneumonitis in a Patient with Chronic Myelomonocytic Leukemia: An Autopsy Case.
Journal: Internal medicine (Tokyo, Japan)
Published: December 16, 2015
Last Updated: 09/26/2026